Search Results - "Páramo, Maria Dolores"

The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study by Izquierdo, Guillermo, Damas, Fátima, Páramo, Maria Dolores, Ruiz-Peña, Juan Luis, Navarro, Guillermo

“…Fingolimod approval was based mainly on two clinical trials, FREEDOMS and TRANSFORMS, which demonstrated the efficacy and safety of fingolimod in patients with…”
Get full text

Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients by Vázquez-Marrufo, Manuel, Galvao-Carmona, Alejandro, Caballero-Díaz, Rocio, Borges, Monica, Paramo, Maria Dolores, Benítez-Lugo, Maria Luisa, Ruiz-Peña, Juan Luis, Izquierdo, Guillermo

“…Functional neuroanatomy of cognitive impairment in multiple sclerosis is currently still a challenge. During the progression of the disease, several cognitive…”
Get full text

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study by Fernández, Oscar, Izquierdo, Guillermo, Fernández, Victoria, Leyva, Laura, Reyes, Virginia, Guerrero, Miguel, León, Antonio, Arnaiz, Carlos, Navarro, Guillermo, Páramo, Maria Dolores, Cuesta, Antonio De la, Soria, Bernat, Hmadcha, Abdelkrim, Pozo, David, Fernandez-Montesinos, Rafael, Leal, Maria, Ochotorena, Itziar, Gálvez, Patricia, Geniz, Maria Angeles, Barón, Francisco Javier, Mata, Rosario, Medina, Cristina, Caparrós-Escudero, Carlos, Cardesa, Ana, Cuende, Natividad

“…Currently available treatments for secondary progressive multiple sclerosis(SPMS) have limited efficacy and/or safety concerns. Adipose-mesenchymal derived…”
Get full text

Rebound after discontinuation of teriflunomide in patients with multiple sclerosis: 2 case reports by Fuerte-Hortigón, A, López Ruiz, R, Hiraldo, JDG, Sánchez Fernández, F, Dotor García-Soto, J, Páramo, María Dolores, Ruiz-Peña, JL, Navarro-Mascarell, G, Eichau, S

“…•Teriflunomide is an oral first-line therapy used in relapsing forms of MS.•The washout period of teriflunomide may be accelerated by cholestyramine.•Clearance…”
Get full text

Adipose-derived mesenchymal stem cells by Fernández, Oscar, Izquierdo, Guillermo, Fernández, Victoria, Leyva, Laura, Reyes, Virginia, Guerrero, Miguel, León, Antonio, Arnaiz, Carlos, Navarro, Guillermo, Páramo, Maria Dolores, Cuesta, Antonio De la, Soria, Bernat, Hmadcha, Abdelkrim, Pozo, David, Fernandez-Montesinos, Rafael, Leal, Maria, Ochotorena, Itziar, Gálvez, Patricia, Geniz, Maria Angeles, Barón, Francisco Javier, Mata, Rosario, Medina, Cristina, Caparrós-Escudero, Carlos, Cardesa, Ana, Cuende, Natividad

“…Background Currently available treatments for secondary progressive multiple sclerosis(SPMS) have limited efficacy and/or safety concerns. Adipose-mesenchymal…”
Get full text